SeekingAlpha · Oct 14, 2026
Insiders Finally Buy Into The Bluerock Private Real Estate Fund
Bluerock Private Real Estate Fund (BPRE) trades 43% below NAV with a 12.7% yield. I expect at least 25% upside in BPRE. Read the full analysis here.

NYSE · BTX
Healthcare · Biotechnology
$8.42
Down-$0.02 (-0.24%)
Updated Oct 24, 2026, 7:26 PM
SID Score
4.4/10
Composite research score
Smart Money
—
Institutional and insider signal
Price performance · BTX
1M range · 21 trading sessions · Daily adjusted prices
Prices through Oct 23, 2026
BTX closed at $8.42 after 21 trading sessions, down 6.86% for the selected period.
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 23, 2026 | $8.42 | $8.48 | $8.31 | $8.42 | 268.43K |
| Oct 22, 2026 | $8.43 | $8.595 | $8.39 | $8.44 | 545.86K |
| Oct 21, 2026 | $8.68 | $8.74 | $8.59 | $8.73 | 422.88K |
| Oct 20, 2026 | $8.50 | $8.615 | $8.425 | $8.60 | 380.25K |
| Oct 19, 2026 | $8.61 | $8.6499 | $8.465 | $8.56 | 509.76K |
| Oct 16, 2026 | $8.68 | $8.6999 | $8.465 | $8.47 | 542.56K |
| Oct 15, 2026 | $8.52 | $8.695 | $8.425 | $8.68 | 581.38K |
| Oct 14, 2026 | $8.99 | $9.10 | $8.75 | $8.77 | 571.02K |
| Oct 13, 2026 | $9.09 | $9.16 | $9.00 | $9.07 | 963.21K |
| Oct 12, 2026 | $9.36 | $9.36 | $9.18 | $9.22 | 316.18K |
| Oct 9, 2026 | $9.35 | $9.425 | $9.2897 | $9.40 | 1.07M |
| Oct 8, 2026 | $9.36 | $9.38 | $9.16 | $9.24 | 596.23K |
| Oct 7, 2026 | $9.35 | $9.4155 | $9.305 | $9.40 | 354.17K |
| Oct 6, 2026 | $9.40 | $9.49 | $9.345 | $9.49 | 479.99K |
| Oct 5, 2026 | $9.24 | $9.38 | $9.24 | $9.38 | 509.77K |
| Oct 2, 2026 | $9.30 | $9.3297 | $9.22 | $9.22 | 487.34K |
| Oct 1, 2026 | $9.02 | $9.23 | $8.98 | $9.16 | 652.65K |
| Sep 30, 2026 | $9.03 | $9.0498 | $8.955 | $8.98 | 611.26K |
| Sep 29, 2026 | $8.97 | $8.99 | $8.8799 | $8.95 | 519.66K |
| Sep 28, 2026 | $9.01 | $9.049 | $8.82 | $8.86 | 365.29K |
| Sep 25, 2026 | $9.04 | $9.065 | $8.97 | $9.04 | 306.06K |
The latest Smart Investors Daily articles mentioning BTX.
Company
Market Activity
Research & News
BTX research
Company profile and research snapshot.
BlackRock Technology and Private Equity Term Trust objective is to provide total return and income through a combination of current income, current gains and long-term capital appreciation. The Trust will invest in equity securities issued by mid - and small capitalization companies that the Trust's adviser believes have above-average earnings growth potential.
Visit company websiteConsensus and target data currently published for this company.
| Date | Firm | Rating | Target |
|---|---|---|---|
| Oct 12, 2022 | Maxim Group | Hold | — |
| Dec 29, 2021 | Cantor Fitzgerald | Overweight | — |
| Oct 6, 2021 | Maxim Group | Buy | — |
| Mar 18, 2019 | Raymond James | Outperform | — |
| Feb 21, 2019 | H.C. Wainwright | Buy | — |
No generated briefing is available yet.
SeekingAlpha · Oct 14, 2026
Bluerock Private Real Estate Fund (BPRE) trades 43% below NAV with a 12.7% yield. I expect at least 25% upside in BPRE. Read the full analysis here.
SeekingAlpha · Sep 30, 2026
OpenAIâs surging revenue, enterprise adoption and IPO outlookâplus risks like losses, privacy and trust. Read why I cannot recommend exposure to the company.
SeekingAlpha · Sep 23, 2026
BTX is rated a Buy and offers diversified public and private equity exposure centered on the AI investment theme. Read more on the fund here.
SeekingAlpha · Jul 8, 2026
BlackRock Technology and Private Equity Term Trust aims for 80% tech exposure, blending public and private holdings. Read the full analysis here.
Interpretive context generated from the platform’s current data sources.
No results
AI research layers have not been published yet.


The latest Smart Investors Daily articles mentioning BTX.